Skip to main content
Get the Weekly ESG Brief

Prestige Consumer Healthcare Inc.

PBHNYSETrackedMarket Data VerifiedHealth CarePharmaceuticals

Coverage
Coverage universe Identity published; no third-party ESG observation yet.
ESG profile reviewed
Last editorial update to this profile.
Quote
Last verified closeObservation time is shown beside the price.
Methodology
How we rateProvider ratings are shown separately, never blended.

Market overview

USD 45.26

Up+USD 0.49 (+1.09%) Day change

Last verified close · As of · USD · Market data via Massive Stock Widgets

The market is closed. This is the last verified closing quote, not an intraday price.

Open
USD 44.88
Previous close
USD 44.77
Day high
USD 45.75
Day low
USD 44.64
Volume
534,762
Market cap
USD 2,144,170,752
Price chart · 1 Year
Prestige Consumer Healthcare Inc. 1 Year price chartPrestige Consumer Healthcare Inc., nyse:PBH, 1 Year price chart in USD. Start USD 63.96, end USD 45.26, high USD 70.21, low USD 44.77, down.
Period1 YearFirst closeUSD 63.96Last closeUSD 45.26Maximum closeUSD 70.21Minimum closeUSD 44.77Period change−USD 18.70Period percentage change−29.24%Chart as ofOct 2, 2026, 1:30 PM GMT+0000
View Chart Data
Representative chart points — 24 of 251
Date and time Open High Low Close Volume
USD 62.84 USD 64.31 USD 62.67 USD 63.96 476,100
USD 59.14 USD 59.47 USD 58.03 USD 58.49 333,600
USD 59.97 USD 60.48 USD 59.19 USD 60.06 386,000
USD 61.44 USD 62.34 USD 61.22 USD 61.74 1,326,300
USD 63.09 USD 63.42 USD 61.86 USD 62.73 241,100
USD 67.56 USD 67.72 USD 65.65 USD 65.80 408,600
USD 66.34 USD 66.85 USD 64.66 USD 65.35 364,100
USD 69.35 USD 69.52 USD 67.91 USD 69.38 434,300
USD 69.97 USD 70.64 USD 69.70 USD 70.21 448,600
USD 64.12 USD 64.70 USD 61.87 USD 61.90 428,000
USD 60.19 USD 60.69 USD 58.89 USD 59.22 490,300
USD 56.07 USD 57.12 USD 55.79 USD 56.84 464,100
USD 59.01 USD 59.15 USD 57.90 USD 58.75 459,300
USD 49.87 USD 52.05 USD 49.61 USD 51.81 750,600
USD 48.32 USD 48.82 USD 47.22 USD 47.53 720,100
USD 47.63 USD 49.50 USD 46.66 USD 46.67 726,100
USD 48.09 USD 48.46 USD 47.32 USD 48.16 538,100
USD 50.51 USD 51.57 USD 48.88 USD 49.92 443,100
USD 51.20 USD 52.66 USD 51.07 USD 51.92 832,300
USD 51.00 USD 51.10 USD 49.73 USD 50.04 576,500
USD 52.50 USD 53.57 USD 52.28 USD 52.64 592,600
USD 47.20 USD 47.49 USD 45.90 USD 46.47 504,000
USD 45.76 USD 46.13 USD 44.64 USD 44.77 731,400
USD 44.88 USD 45.75 USD 44.60 USD 45.26 534,800

Company Profile & Business Model Overview

Prestige Consumer Healthcare Inc. (PBH: NYSE) markets, manufactures and distributes branded over‑the‑counter healthcare and household products across the United States, Canada, Australia and select international markets; its portfolio includes consumer health brands sold through retail outlets and e‑commerce channels. The company operates as a mid‑cap consumer healthcare manufacturer and distributor headquartered in Tarrytown, New York.

Sustainability Strengths & Catalysts (Pros)

  • Published an inaugural sustainability report and subsequently a FY25 sustainability report outlining initiatives across waste management, supply chain management, water conservation, GHG emissions and extended producer responsibility, indicating formalize
  • ESG framework centers on three pillars — inclusive workforce, responsible corporate citizenship, and producing sustainably — demonstrating structured governance of social and environmental priorities and public reporting of related programs.
  • Public disclosures note initiatives on product quality management, consumer feedback monitoring and internal accountability, reflecting attention to product safety and operational controls relevant to ESG performance.

Material Risks & Governance Concerns (Cons)

  • As a consumer packaged goods manufacturer with global sourcing and manufacturing, the company faces supply‑chain environmental risks (GHG emissions, water use, waste) and potential regulatory exposure tied to product ingredients and packaging extended pro
  • Growing public scrutiny and regulatory expectations around plastic packaging, chemical disclosures and sustainability claims present reputational and compliance risks as the company scales sustainability commitments across diverse markets.

Related ESG Peer Equities

Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.

Explore Health Care Peers →

ESG & Sustainability Rating Breakdown

Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.

Audited Methodology

Coverage PendingThird-Party ESG Coverage Under Review

Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Data integrity and methodology

MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.

FAQ

Frequently Asked Questions

Direct answers on sustainability scores, risk methodologies, and peer rankings.

What is Prestige Consumer Healthcare Inc. (PBH)'s ESG rating and sustainability score?

Formal published scorecards from MSCI and Sustainalytics are under ongoing review for Prestige Consumer Healthcare Inc. (PBH). The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.

Is Prestige Consumer Healthcare Inc. considered an ESG leader or laggard in Health Care?

Independent benchmark status for Prestige Consumer Healthcare Inc. is evaluated relative to Health Care peers once third-party coverage publishes official methodology scores.

What are the main ESG risks and controversies for Prestige Consumer Healthcare Inc.?

Key material risks for Prestige Consumer Healthcare Inc. include: As a consumer packaged goods manufacturer with global sourcing and manufacturing, the company faces supply‑chain environmental risks (GHG emissions, water use, waste) and potential regulatory exposure tied to product ingredients and packaging extended pro; Growing public scrutiny and regulatory expectations around plastic packaging, chemical disclosures and sustainability claims present reputational and compliance risks as the company scales sustainability commitments across diverse markets.. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.

How does The Impact Investor evaluate ESG stock profiles?

The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.